logo
episode-header-image
Jan 2024
26m 16s

JP Morgan Healthcare Conference Highligh...

The Motley Fool
About this episode
Weight loss drugs are taking center spotlight, but other developing treatments could change how we live. Deidre Woollard caught up with Motley Fool biotech analyst Karl Thiel to discuss: - Biogen’s next shot at an Alzheimer’s treatment. - Why companies can’t “muscle their way” into making new molecules. - How NVIDIA could change drug development.  - Moderna ... Show More
Up next
Yesterday
The Pitfalls of Selling Stocks (and How to Avoid Them)
Some of the biggest mistakes investors make aren’t the stocks they buy - they’re the ones they sell. In today’s episode of Motley Fool Money, host Emily Flippen is joined by Fool analysts Jason Hall and Jeff Santoro to look back at some of The Motley Fool’s most painful sell deci ... Show More
19m 51s
Nov 24
Reckless Earnings Predictions: ZM, BBY, DE
We enter Thanksgiving week with a plate full of reckless predictions featuring Zoom (reports today), Best Buy (reports tomorrow morning), and Deere & Co. (reports tomorrow morning). Rick Munarriz, David Meier, and Tim Beyers: - Forecast a “miss, beat, or beat and raise” for Z ... Show More
24 m
Nov 23
Interview with Mark Matson: Experiencing the American Dream
What’s the first step in building wealth? How do we know if we’re on track financially? What does abundance look like? Motley Fool contributor Rich Lumelleau talks with Matson Money Founder and CEO Mark Matson, author of Experiencing The American Dream: How to Invest Your Time, E ... Show More
19m 1s
Recommended Episodes
Jun 2016
Bloomberg Surveillance: Bloomberg BNA's Eleanor Tyler on pharma
Bloomberg BNA's Eleanor Tyler joins Tom Keene and Mike McKee to discuss pharmaceutical mergeres, tax inversions, drug pricing, and the renewed efforts by the Federal Trade Commission to regulate an increasingly complicated industry. Learn more about your ad-choices at https://www ... Show More
6m 38s
Dec 2018
Healthcare: China’s Biotech Revolution
China’s biotech industry is booming. Driven by vast government funding and Western partnerships, the country is introducing new commercial drugs at a faster pace than ever before. But could controversial topics such as human genetic engineering derail its accelerated growth? Shan ... Show More
36m 3s
Sep 2021
The future of vaccines
The founders of German biotechnology company BioNTech were researching how to fight cancers using messenger RNA, "the unloved cousin of DNA", when covid-19 first appeared and they realised mRNA could be used to make a vaccine for the disease. Financial Times journalist Joe Miller ... Show More
17m 28s
Mar 2023
#661: Dr. Peter Attia — The Science and Art of Longevity, Optimizing Protein, Alcohol Rules, Lessons from Glucose Monitoring with CGMs, Boosting Your VO2 Max, Preventing Alzheimer's Disease, Early Cancer Detection, How to Use DEXA Scans, Nature’s Longevity Drug, and More
<p><strong><em>Brought to you by&nbsp;</em></strong><a href="http://wealthfront.com/tim" rel="noopener noreferrer" target="_blank"><strong><em>Wealthfront</em></strong></a><strong><em>&nbsp;high-yield savings account, </em></strong><a href="http://helixsleep.com/tim" rel="noopene ... Show More
2h 22m
Mar 2023
Antibiotics: How to fix a broken market
Antibiotics stopped providing big gains for pharmaceutical companies decades ago, but as bacteria become more resistant to drugs, the world needs new classes of antibiotics to be discovered if we want to prevent the next global health crisis.Dr Tina Joshi, Associate Professor of ... Show More
18m 23s
Nov 2022
#633: Chris Palmer, MD, of Harvard Medical School — Optimizing Brain Energy for Mental Health, The Incredible Potential of Metabolic Psychiatry, Extraordinary Case Studies, and Harnessing Mitochondria for Anxiety, Depression, OCD, PTSD, and More
<p><strong><em>Brought to you by&nbsp;</em></strong><a href="http://levels.link/tim" rel="noopener noreferrer" target="_blank"><strong><em>Levels</em></strong></a><strong><em>&nbsp;real-time feedback on how diet impacts your health, </em></strong><a href="http://athleticgreens.co ... Show More
1h 59m
Jan 2024
Novo Nordisk (Ozempic)
<p>Last year Novo Nordisk, the Danish pharmaceutical company behind Ozempic and Wegovy, overtook LVMH to become Europe’s most valuable company. And the pull for Acquired to finally tackle healthcare (18% of US GDP!) became too strong for us to resist. While we didn’t know much ab ... Show More
3h 44m
Oct 2023
Ozempic’s Success Is Bad News for Rivals
Bloomberg News Health Reporter Madison Muller discusses how the drug Ozempic could cut demand for big-money drugs targeting a wide range of maladies, even Alzheimer’s. Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.See omnystudio.com/listener for privacy information ... Show More
7m 10s
Jun 2020
Learning to Love Big Pharma
Gilead Sciences announced today that it will charge the U.S. government and other developed countries $390 per vial for its coronavirus-fighting drug remdesivir. That begins to answer a big question as drug companies race to find treatments and develop vaccines for the virus: How ... Show More
13m 27s
Jun 2021
Moderna: The Software of Life - [Business Breakdowns, EP. 13]
Today, we will be diving into Moderna. Founded in 2010, Moderna and its innovative RNA platform made headlines after developing one of the first COVID vaccines. We treated this Breakdown slightly different than our other episodes. I’m joined today by two guests. First, I am joine ... Show More
1h 9m